Abstract
Research and innovation are integral to the advancement of medical knowledge and improvements in clinical care. While this progress is excellent for patients and cardiovascular care, the pace is accelerating and the landscape ever more competitive. It thus mandates academic institutions and leading-edge hospitals to organize research and innovation endeavors deliberately or risk being left behind. Modern research is incredibly complex in concept and technology, and the ability to make high-impact observations is no longer readily within the reach of a single investigator, but requires a sophisticated team.
Research teams of today and tomorrow will need to bring together diverse technology, scientific expertise, in-depth observations, and large datasets, to derive fundamental new insights. The University of Ottawa Heart Institute developed a new research strategic plan for the entire Ottawa region, to fast track innovation to impact. Brainstorming sessions lead to cutting-edge ideas that translate to interdisciplinary proposals that are the core activities of the Innovation Hubs. Patient partners are also critical to bring into focus the priorities from their point of view and what the research results will mean for their lives.
Therefore, the research teams of the future will need to be multidisciplinary, nimble, efficient, and outcome-oriented, accelerating excellence in care beyond imagination today.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nguyen HV, de Oliveira C, Wijeysundera HC, Wong WW, Woo G, Grootendorst P, et al. Canada's contribution to global research in cardiovascular diseases. Can J Cardiol. 2013;29:742–6.
de Oliveira C, Nguyen VH, Wijeysundera HC, Wong WW, Woo G, Liu PP, et al. How much are we spending? The estimation of research expenditures on cardiovascular disease in Canada. BMC Health Serv Res. 2012;12:281.
de Oliveira C, Nguyen HV, Wijeysundera HC, Wong WW, Woo G, Grootendorst P, et al. Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis. CMAJ Open. 2013;1:E83–90.
Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg. 1968;5:334–9.
Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–80.
Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842–50.
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.
Fitzgerald K, White S, Borodovsky A, Bettencourt BR, Strahs A, Clausen V, et al. A highly durable RNAi therapeutic inhibitor of PCSK9. N Engl J Med. 2017;376:41–51.
Suhr OB, Coelho T, Buades J, Pouget J, Conceicao I, Berk J, et al. Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study. Orphanet J Rare Dis. 2015;10:109.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Liu, P.P., Hosey, A.M. (2019). Multidisciplinary Heart Teams for Cutting-Edge Research. In: Mesana, T. (eds) Heart Teams for Treatment of Cardiovascular Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-19124-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-19124-5_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19123-8
Online ISBN: 978-3-030-19124-5
eBook Packages: MedicineMedicine (R0)